Huh, maybe they will splain this concept to FDA. Nice. BTW, where have we heard the CAUSE discussion before...hint...RIGHT HERE. WOW, you mean running endless Amyloid Trials for the last 30+ years on taxpayers dime was a mistake??
“Unraveling the complex biological mechanisms that cause Alzheimer’s disease is critical for therapeutic development,” said NIH Director Francis S. Collins, M.D., Ph.D. “AMP AD 2.0 aims to add greater precision to the molecular maps developed in the first iteration of this program. This will identify biological targets and biomarkers to inform new therapeutic interventions for specific disease subtypes.”
Market Data 
Markets 
